| Bid Price | High Price | ||
|---|---|---|---|
| Ask Price | Low Price | ||
| Open Price | Spread | ||
| Prev Close | Volume |
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| May 24, 2019 | 0.00 | 0.00 | 0.00 | 60.00 | 0 |
| May 23, 2019 | 60.00 | 60.00 | 59.00 | 59.75 | 4,004 |
| May 22, 2019 | 63.50 | 63.50 | 60.00 | 60.25 | 30,238 |
| May 21, 2019 | 66.70 | 66.70 | 66.70 | 65.50 | 1,484 |
| May 20, 2019 | 65.84 | 67.50 | 64.00 | 66.25 | 125,560 |
| Name | Silence Therapeutics | Epic | SLN |
|---|---|---|---|
| ISIN | GB00B9GTXM62 | Currency | GBX |
| Type | Equity | Trading Segment | AMSM |
| Record Status | Active | Trading Status | Closed |
| Industry | Health Care | Sector | Biotechnology |
| EMS | 5,000 | Prev Close | 60.00 |
| Shares in Issue (m) | 71.56 | Market Cap (£m) | 42.76 |
| PE Ratio | -25.98 | Div per Share (p) | 0.00 |
| Div Yield | 0.00 | Div Cover | 0.00 |
| EPS | -2.30 | EPS Growth (%) | 80.99 |
| PEG | -0.32 | DPS Growth (%) | n/a |
| ROCE | -7.22 | Net Gearing | -72.88 |
| Quick Ratio | 17.14 | Current Ratio | 17.14 |
| Date | Broker | Recomm. | Price | Old Target | New Target | Notes |
|---|---|---|---|---|---|---|
| 02 May | Peel Hunt | Under Review | 60.00 | - | - | Under Review |
| 25 Apr | Peel Hunt | Under Review | 60.00 | - | - | Under Review |
| 02 Apr | Peel Hunt | Under Review | 60.00 | - | - | Under Review |
| 27 Mar | Peel Hunt | Under Review | 60.00 | - | - | Under Review |
| 11 Mar | Peel Hunt | Under Review | 60.00 | - | - | Under Review |
| Date | Director | Type | Volume / Price | Trade Value |
|---|---|---|---|---|
| 03 Aug 2017 | Alistair Gray | Buy | 3,848 @ 129.75p | £4,992.78 |
| 31 Jul 2017 | Dr Andrew Richards | Buy | 7,000 @ 146.88p | £10,281.60 |
| 18 Apr 2016 | Ali Mortazavi | Buy | 160,000 @ 125.00p | £200,000.00 |
| 18 Apr 2016 | Dr Stephen Parker | Buy | 6,478 @ 123.31p | £7,988.02 |
| 28 Nov 2012 | Ali Mortazavi | Buy | 2,400,000 @ 2.50p | £60,000.00 |
